US 11389449
Treatment of metabolic syndrome with an sGC stimulator
granted A61KA61K31/506A61K45/06
Quick answer
US patent 11389449 (Treatment of metabolic syndrome with an sGC stimulator) held by Cyclerion Therapeutics, Inc. expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cyclerion Therapeutics, Inc.
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/506, A61K45/06, A61K9/0053, A61P